Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5834326 | Journal of Ethnopharmacology | 2016 | 60 Pages |
Abstract
Terminalia sericea contains secondary metabolites which are valuable in the treatment of a variety of human infections, including community acquired infections which may be prevalent in developing countries. The degree of toxicity reported in various extracts warrants further exploration of the cytotoxicity of the plant species, both against normal human cell lines and in vivo. Moreover, the acetylcholinesterase inhibitory and anti-inflammatory effects also need to be further investigated as there are only a few reports from the literature on these aspects. There is also a need to further understand the mode of action of the extracts against various enzymes relating to inflammation. Antioxidant activity of the plant extracts against various forms of free radicals needs to be investigated. Although T. sericea is reported to be used for ethnoveterinary infections, there are no scientific reports on the anti-parasitic activity of the plant species against common animal parasites.
Keywords
COX2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium saltIC50,Terminalia sericeaCombretaceae4-NQOMBC2,2-diphenyl-1-picryl-hydrazylMFCABTSDPPHXanthine oxidase4-nitroquinoline-1-oxide50% inhibitory concentrationcyclooxygenaseAChEEthnomedicineAcetylcholinesteraseminimum bactericidal concentrationMinimum fungicidal concentrationPharmacologyNitric oxide
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
N.I. Mongalo, L.J. McGaw, T.V. Segapelo, J.F. Finnie, J. Van Staden,